TLDR CME Group posted Q1 adjusted EPS of $3.36, beating the $3.31 consensus estimate Revenue hit a record $1.9 billion, up 14% year-over-year, topping the $1.85TLDR CME Group posted Q1 adjusted EPS of $3.36, beating the $3.31 consensus estimate Revenue hit a record $1.9 billion, up 14% year-over-year, topping the $1.85

CME Group (CME) Stock Dips Despite Best Quarter in Company History

2026/04/22 19:24
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • CME Group posted Q1 adjusted EPS of $3.36, beating the $3.31 consensus estimate
  • Revenue hit a record $1.9 billion, up 14% year-over-year, topping the $1.85 billion estimate
  • Average daily volume rose 22% to a record 36.2 million contracts, with records across all six asset classes
  • Net income climbed 20% to $1.2 billion; adjusted operating income reached $1.4 billion
  • CME stock edged down 1.5% in pre-market trading despite the strong results

CME Group turned in a record-breaking first quarter in 2026, beating Wall Street on both earnings and revenue. The stock still slipped 1.5% in pre-market trading.

Adjusted EPS came in at $3.36, topping the analyst consensus of $3.31. Revenue reached $1.9 billion, up 14% from the same period last year and ahead of the $1.85 billion estimate.

The standout number was average daily volume. CME recorded 36.2 million contracts per day — up 22% year-over-year — with records set across all six asset classes it operates.


CME Stock Card
CME Group Inc., CME

Net income for the quarter was $1.2 billion, a 20% jump from Q1 2025. Adjusted operating income climbed to $1.4 billion.

Clearing and transaction fees — CME’s core revenue line — hit a record $1.5 billion for the quarter. Market data revenue also set a new high at $224 million.

The total average rate per contract was $0.652. Non-U.S. average daily volume reached a record 11.4 million contracts, up 30% compared with Q1 2025.

Volatility Fuels Volumes

CME’s business model benefits when markets move sharply. When uncertainty rises, traders and institutions rush to hedge positions using futures and derivatives — CME’s core products.

During Q1, elevated uncertainty around global interest rates and geopolitical tensions pushed more market participants to CME’s platform. That translated directly into higher trading volumes and fees.

The exchange saw strong demand across interest rate and equity index products in particular. These categories tend to see the most activity when rate expectations are shifting.

Capital Returns

CME paid out approximately $2.7 billion in dividends during the quarter. The company also repurchased $536 million in common stock.

As of March 31, 2026, CME held $2.6 billion in cash and carried $3.4 billion in debt.

Despite the pre-market dip, the underlying numbers pointed to strong operational momentum. Non-U.S. volumes growing 30% year-over-year suggests international demand for CME’s products is accelerating.

The record market data revenue of $224 million is also worth flagging. That segment tends to be high-margin and recurring, adding some stability to the fee-based volume business.

Q1 2026 marks CME’s strongest quarter on record by several key measures, with records across revenue, volume, clearing fees, and market data.

The post CME Group (CME) Stock Dips Despite Best Quarter in Company History appeared first on CoinCentral.

Market Opportunity
SIX Logo
SIX Price(SIX)
$0.00889
$0.00889$0.00889
0.00%
USD
SIX (SIX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!